Investor List:

Top Therapeutics Seed Investors in Los Angeles / Southern California (25)

Know someone who's actively diligencing and investing? Add them to this list.
About this list
We’ve compiled a list of the top Therapeutics investors. The goal is to help Founders find the best investors to target and get introduced to.
Photo of Geoffrey Smith, Managing Partner at Digitalis Ventures
Geoffrey Smith
Digitalis Ventures·Managing Partner
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in New York (NY), Investors in Los Angeles (CA), Investors in San Francisco (CA), Investors in Boston (MA)
Investors in BioTech (Series B), Investors in BioTech (Seed), Investors in Manufacturing (Series B), Investors in BioTech (Series A), Investors in Manufacturing (Seed), Investors in Manufacturing (Series A), Investors in Health IT (Series A), Investors in Health & Hospital Services (Series B), Investors in BioTech (Seed), Investors in BioTech (Seed), Investors in BioTech (Seed), Investors in Los Angeles / Southern California (Other Lists), Investors in BioTech (Seed), Investors in New York City (Other Lists), Investors in Health IT (Seed), Investors in Health IT (Seed), Investors in Health IT (Seed), Investors in Health & Hospital Services (Series A), Investors in Health & Hospital Services (Seed), Investors in San Francisco Bay Area (Other Lists), Investors in Health & Hospital Services (Seed), Investors in Manufacturing (Seed), Investors in Health & Hospital Services (Seed), Investors in Health & Hospital Services (Seed), Investors in Manufacturing (Seed), Investors in Manufacturing (Seed), Investors in BioTech (Series A), Investors in BioTech (Series A), Investors in Manufacturing (Seed), Investors in BioTech (Series A), Investors in BioTech (Series A), Investors in Health IT (Series A), Investors in Health IT (Series A), Investors in Health IT (Series A), Investors in Health IT (Series A), Investors in Health & Hospital Services (Series A), Investors in Manufacturing (Series A), Investors in Health & Hospital Services (Series A), Investors in Health & Hospital Services (Series A), Investors in Manufacturing (Series A), Investors in BioTech (Series B), Investors in Manufacturing (Series A), Investors in Health & Hospital Services (Series A), Investors in BioTech (Series B), Investors in Manufacturing (Series A), Investors in BioTech (Series B), Investors in Health IT (Series B), Investors in BioTech (Series B), Investors in Health IT (Series B), Investors in Health IT (Series B), Investors in Manufacturing (Series B), Investors in Health IT (Series B), Investors in Manufacturing (Series B), Investors in Health & Hospital Services (Series B), Investors in Health & Hospital Services (Series B), Investors in Manufacturing (Series B), Investors in Health & Hospital Services (Series B), Investors in Health & Hospital Services (Series B), Investors in Manufacturing (Series B), Investors in Boston / New England (Other Lists), Investors in Diagnostics (Series A), Investors in Diagnostics (Series A), Investors in Digital Health (Seed), Investors in Digital Health (Series B), Investors in Diagnostics (Seed), Investors in Digital Health (Series B), Investors in Diagnostics (Series B), Investors in Diagnostics (Series A), Investors in Diagnostics (Series B), Investors in Digital Health (Series A), Investors in Diagnostics (Seed), Investors in Diagnostics (Series B), Investors in Diagnostics (Series A), Investors in Diagnostics (Seed), Investors in Digital Health (Series A), Investors in Diagnostics (Series B), Investors in Digital Health (Seed), Investors in Digital Health (Series B), Investors in Diagnostics (Seed), Investors in Digital Health (Series A), Investors in Digital Health (Series B), Investors in Digital Health (Seed), Investors in Diagnostics (Series B), Investors in Diagnostics (Seed), Investors in Diagnostics (Series A), Investors in Digital Health (Seed), Investors in Digital Health (Series A), Investors in Digital Health (Series B), Investors in Therapeutics (Seed), Investors in Therapeutics (Seed), Investors in Therapeutics (Series A), Investors in Therapeutics (Series A), Investors in Therapeutics (Series A), Investors in Therapeutics (Seed), Investors in Therapeutics (Series B), Investors in Therapeutics (Series A), Investors in Therapeutics (Series B), Investors in Therapeutics (Series A), Investors in Therapeutics (Seed), Investors in Therapeutics (Series B), Investors in Therapeutics (Series B), Investors in Therapeutics (Series B), Investors in Therapeutics (Seed), Investors in Health IT (Seed), Investors in Health IT (Seed), Investors in Health IT (Series B), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in Health & Hospital Services (Seed)
Photo of Samuel Bjork, Partner at Digitalis Ventures
Samuel Bjork
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in New York (NY), Investors in Los Angeles (CA), Investors in San Francisco (CA)
Photo of Fabian Hansen, Managing Director at Presight Capital
Fabian Hansen
Presight Capital·Managing Director
Sweet spot: $10.0M
Range: $500K - $20.0M
Investors in Los Angeles (CA)
Investors in Consumer Health (Series B), Investors in BioTech (Series B), Investors in Consumer Health (Series A), Investors in BioTech (Seed), Investors in Consumer Health (Seed), Investors in FinTech (Series B), Investors in BioTech (Series A), Investors in Health IT (Series A), Investors in Health & Hospital Services (Series B), Investors in BioTech (Seed), Investors in Los Angeles / Southern California (Other Lists), Investors in Consumer Health (Seed), Investors in FinTech (Seed), Investors in Health IT (Seed), Investors in Health & Hospital Services (Series A), Investors in Health & Hospital Services (Seed), Investors in BioTech (Series A), Investors in Consumer Health (Series A), Investors in FinTech (Series A), Investors in Health IT (Series A), Investors in Health & Hospital Services (Series A), Investors in BioTech (Series B), Investors in Consumer Health (Series B), Investors in FinTech (Series B), Investors in Health IT (Series B), Investors in Health & Hospital Services (Series B), Investors in DeepTech (Series A), Investors in DeepTech (Series B), Investors in DeepTech (Seed), Investors in DeepTech (Series A), Investors in DeepTech (Seed), Investors in DeepTech (Series B), Investors in Therapeutics (Seed), Investors in Therapeutics (Series A), Investors in Therapeutics (Seed), Investors in Therapeutics (Series B), Investors in Therapeutics (Series B), Investors in Therapeutics (Series A), Investors in Health IT (Seed), Investors in FinTech (Series A), Investors in Health IT (Series B), Investors in FinTech (Seed), Investors in Health & Hospital Services (Seed)
Photo of Teymour Boutros-Gali, Managing Partner at Bold Capital Partners
Teymour Boutros-Gali
Bold Capital Partners·Managing Partner
Sweet spot: $4.0M
Range: $500K - $10.0M
Investors in Santa Monica (CA)
Investors in AR/VR (Series A), Investors in AR/VR (Seed), Investors in Consumer Health (Series A), Investors in IoT (Seed), Investors in Web3/Blockchain (Seed), Investors in Web3/Blockchain (Series A), Investors in BioTech (Seed), Investors in IoT (Series A), Investors in Consumer Health (Seed), Investors in BioTech (Series A), Investors in AI (Seed), Investors in Diverse Investors (Other Lists), Investors in AI (Seed), Investors in Investors who were founders (Other Lists), Investors in Investors who invested in female founders (Other Lists), Investors in AR/VR (Seed), Investors in BioTech (Seed), Investors in AI (Series A), Investors in Web3/Blockchain (Seed), Investors in Investors who invested in diverse founders (Other Lists), Investors in Consumer Health (Seed), Investors in Los Angeles / Southern California (Other Lists), Investors in IoT (Seed), Investors in AI (Series A), Investors in AR/VR (Series A), Investors in BioTech (Series A), Investors in Web3/Blockchain (Series A), Investors in Consumer Health (Series A), Investors in IoT (Series A), Investors in Digital Health (Seed), Investors in Digital Health (Series A), Investors in Wellness & Fitness (Series A), Investors in DeepTech (Series A), Investors in Wellness & Fitness (Seed), Investors in Wellness & Fitness (Seed), Investors in Wellness & Fitness (Series A), Investors in DeepTech (Seed), Investors in DeepTech (Series A), Investors in DeepTech (Seed), Investors in Therapeutics (Seed), Investors in Therapeutics (Series A), Investors in Therapeutics (Seed), Investors in Therapeutics (Series A), Investors in Digital Health (Series A), Investors in Digital Health (Seed)
Photo of Jason Camm, Managing Director at Thiel Capital
Jason Camm
Thiel Capital·Managing Director
Sweet spot: $1.5M
Range: $100K - $1.5M
Investors in West Hollywood (CA)
Photo of Mark Hahs, Managing Partner at VentureDNA
Mark Hahs
VentureDNA·Managing Partner
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Bakersfield (CA)
Investors in Payments (Seed), Investors in IoT (Seed), Investors in Payments (Series A), Investors in BioTech (Seed), Investors in IoT (Series A), Investors in BioTech (Series A), Investors in Health IT (Series A), Investors in BioTech (Seed), Investors in Los Angeles / Southern California (Other Lists), Investors in Health IT (Seed), Investors in IoT (Seed), Investors in Health & Hospital Services (Series A), Investors in Payments (Seed), Investors in Health & Hospital Services (Seed), Investors in BioTech (Series A), Investors in Health IT (Series A), Investors in IoT (Series A), Investors in Payments (Series A), Investors in Health & Hospital Services (Series A), Investors in Digital Health (Seed), Investors in Digital Health (Series A), Investors in Therapeutics (Seed), Investors in Therapeutics (Series A), Investors in Therapeutics (Seed), Investors in Therapeutics (Series A), Investors in Health IT (Seed), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in Health & Hospital Services (Seed)
Photo of Paul Deneys, Vice President at Thiel Capital
Paul Deneys
Thiel Capital·Vice President
Sweet spot: $1.5M
Range: $100K - $1.5M
Investors in West Hollywood (CA)
Photo of Daniel Lennon, Venture Partner at Palo Santo VC
Daniel Lennon
Palo Santo VC·Venture Partner
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Los Angeles (CA)